{"id":32688,"date":"2026-05-11T11:23:41","date_gmt":"2026-05-11T11:23:41","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=32688"},"modified":"2026-05-11T11:23:41","modified_gmt":"2026-05-11T11:23:41","slug":"coretissue-launches-acl-clinical-cohort-study","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","title":{"rendered":"\u30b3\u30a2\u30c6\u30a3\u30c3\u30b7\u30e5\u304cACL\u81e8\u5e8a\u30b3\u30db\u30fc\u30c8\u7814\u7a76\u3092\u958b\u59cb"},"content":{"rendered":"<p><a href=\"https:\/\/www.coretissue.com\/\">\u30b3\u30a2\u30c6\u30a3\u30c3\u30b7\u30e5\u30fb\u30d0\u30a4\u30aa\u30a8\u30f3\u30b8\u30cb\u30a2\u30ea\u30f3\u30b0<\/a> \u533b\u7642\u6a5f\u5668\u30d9\u30f3\u30c1\u30e3\u30fc\u4f01\u696d\u3067\u3042\u308b CTBE \u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a\u6771\u4eac\u90fd\u6e2f\u533a\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\u793e\u9577\u517c CEO\uff1a\u67f4\u7530 \u54f2\u4e5f\u3001\u4ee5\u4e0b\u300cCTBE\u300d\uff09\u306f\u3001\u5f53\u793e\u304c\u30b9\u30dd\u30f3\u30b5\u30fc\u3092\u52d9\u3081\u308b\u533b\u7642\u6a5f\u5668\u300cTissue Regenerative Ligament\u300d\uff08\u958b\u767a\u30b3\u30fc\u30c9\uff1aCT-ACL001\uff09\u306b\u3088\u308b\u524d\u5341\u5b57\u976d\u5e2f\uff08ACL\uff09\u518d\u5efa\u8853\u306e\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u3001\u5b89\u5168\u6027\u30b3\u30db\u30fc\u30c8\u306b\u304a\u3051\u308b\u5b89\u5168\u6027\u8a55\u4fa1\u304c\u7d42\u4e86\u3057\u3001\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3092\u691c\u8a3c\u3059\u308b\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u30b3\u30db\u30fc\u30c8\u3092\u958b\u59cb\u3057\u305f\u3053\u3068\u3092\u304a\u77e5\u3089\u305b\u3057\u307e\u3059\u3002\u672c\u7121\u4f5c\u70ba\u5316\u6bd4\u8f03\u30b3\u30db\u30fc\u30c8\u306f\u3001\u60a3\u8005\u81ea\u8eab\u306e\u30cf\u30e0\u30b9\u30c8\u30ea\u30f3\u30b0\u30b9\u8171\u3092\u7528\u3044\u305fACL\u518d\u5efa\u8853\u306e\u6a19\u6e96\u6cbb\u7642\u3092\u5bfe\u7167\u7fa4\u3068\u3057\u3001\u5168\u56fd6\u65bd\u8a2d\u3067\u5b9f\u65bd\u3055\u308c\u307e\u3059\uff1a\u6771\u4eac\u5973\u5b50\u533b\u79d1\u5927\u5b66\u75c5\u9662\uff08\u6cbb\u9a13\u30b3\u30fc\u30c7\u30a3\u30cd\u30fc\u30bf\u30fc\u306e\u5ca1\u5d0e\u5065\u6559\u6388\u304c\u6240\u5c5e\uff09\u3001\u5f18\u524d\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3001\u5e83\u5cf6\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u3001\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u3001\u9806\u5929\u5802\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u9806\u5929\u5802\u75c5\u9662\u3001\u795e\u6238\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\uff0850\u97f3\u9806\uff09\u3002.<\/p>\n<p>\u306a\u304a\u3001\u5b89\u5168\u6027\u8a55\u4fa1\u30b3\u30db\u30fc\u30c8\u306e\u521d\u671f\u7d50\u679c\u306b\u3064\u3044\u3066\u306f\u3001\u672c\u5e745\u670820\u65e5\u304b\u3089\u958b\u50ac\u3055\u308c\u308b\u7b2c22\u56de\u6b27\u5dde\u30b9\u30dd\u30fc\u30c4\u5916\u50b7\u819d\u95a2\u7bc0\u93e1\u5b66\u4f1a\uff08ESSKA\uff09\u306b\u304a\u3044\u3066\u3001\u6771\u4eac\u5973\u5b50\u533b\u79d1\u5927\u5b66\u6574\u5f62\u5916\u79d1\u306e\u4f0a\u85e4\u96c5\u6587\u8b1b\u5e2b\u304c\u767a\u8868\u3059\u308b\u4e88\u5b9a\u3067\u3059\u3002.<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/olympus-partners-endorobotics-to-boost-surgical-endoscopy\/\" rel=\"bookmark\">\u30aa\u30ea\u30f3\u30d1\u30b9\u3001EndoRobotics\u793e\u3068\u63d0\u643a\u3057\u3001\u5916\u79d1\u7528\u5185\u8996\u93e1\u691c\u67fb\u3092\u5f37\u5316<\/a><\/h4>\n<p>\u7121\u4f5c\u70ba\u5316\u30b3\u30db\u30fc\u30c8\u306e\u6982\u8981\uff08\u8a73\u7d30\u306f\u81e8\u5e8a\u8a66\u9a13\u516c\u958b\u60c5\u5831\u3092\u3054\u53c2\u7167\u304f\u3060\u3055\u3044\uff09<\/p>\n<p>\u6cbb\u9a13\u7528\u6a5f\u5668\u7d44\u7e54\u518d\u751f\u976d\u5e2f\uff08\u958b\u767a\u30b3\u30fc\u30c9\uff1aCT-ACL001\uff09<br \/>\n\u5bfe\u8c61\u75be\u60a3\u524d\u5341\u5b57\u976d\u5e2f\u640d\u50b7\uff08\u518d\u5efa\u304c\u5fc5\u8981\uff09<br \/>\n\u76ee\u6a19\u75c7\u4f8b\u6570CT-ACL001\u518d\u5efa\u7fa438\u4f8b\u3001\u81ea\u5bb6\u8171\u518d\u5efa\u7fa419\u4f8b<br \/>\n\u5b9f\u65bd\u4e88\u5b9a\u6642\u671f2026\u5e745\u6708\u958b\u59cb<br \/>\n\u4eca\u5f8c\u306e\u4e88\u5b9a\u672c\u8a66\u9a13\u306e\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u7d42\u4e86\u5f8c\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u533b\u7642\u6a5f\u5668\u306e\u88fd\u9020\u8ca9\u58f2\u627f\u8a8d\u7533\u8acb\u3092\u884c\u3046\u4e88\u5b9a\u3067\u3059\u3002.<\/p>\n<p>\u672c\u81e8\u5e8a\u8a66\u9a13\u3092\u542b\u3080\u7814\u7a76\u958b\u767a\u306f\u3001\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb\uff08AMED\uff09\u306e\u52a9\u6210\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002.<\/p>\n<p><strong>\u30bd\u30fc\u30b9 <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260510603214\/en\/Japanese-Medtech-Startup-CoreTissue-BioEngineering-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment\">\u30d3\u30b8\u30cd\u30b9\u30ef\u30a4\u30e4\u30fc<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>CoreTissue BioEngineering Inc. (\u201cCTBE\u201d), a medical device start-up announces that the safety evaluation in the safety cohort of its clinical trial for anterior cruciate ligament (ACL) reconstruction with the medical device &#8220;Tissue Regenerative Ligament&#8221; (development code: CT-ACL001) sponsored by the company has been completed, and the randomized controlled cohort to verify safety and efficacy has been initiated. This randomized controlled cohort will use the standard treatment of ACL reconstruction using the patient&#8217;s own hamstring tendon as the control group and will be conducted at six facilities nationwide: Tokyo Women&#8217;s Medical University Hospital (where Professor Dr. Ken Okazaki, the clinical trial coordinator, is affiliated), Hirosaki University Hospital, Hiroshima University Hospital, Hokkaido [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":32689,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,206],"tags":[150,6546,12897,12895,12896],"ppma_author":[205],"class_list":["post-32688","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-biotech","category-health-tech","category-japan","category-news","category-regional","tag-biotech","tag-clinical-trial","tag-coretissue-bioengineering","tag-health-technology","tag-medical-devices"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CoreTissue Starts Randomized ACL Trial<\/title>\n<meta name=\"description\" content=\"CoreTissue BioEngineering has launched a randomized controlled cohort study for its ACL reconstruction treatment clinical trial in Japan.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CoreTissue Starts Randomized ACL Trial\" \/>\n<meta property=\"og:description\" content=\"CoreTissue BioEngineering has launched a randomized controlled cohort study for its ACL reconstruction treatment clinical trial in Japan.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-11T11:23:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30b3\u30a2\u30c6\u30a3\u30c3\u30b7\u30e5\u304c\u7121\u4f5c\u70ba\u5316ACL\u8a66\u9a13\u3092\u958b\u59cb","description":"\u30b3\u30a2\u30c6\u30a3\u30c3\u30b7\u30e5\u30fb\u30d0\u30a4\u30aa\u30a8\u30f3\u30b8\u30cb\u30a2\u30ea\u30f3\u30b0\u306f\u3001ACL\u518d\u5efa\u6cbb\u7642\u81e8\u5e8a\u8a66\u9a13\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u30b3\u30db\u30fc\u30c8\u8a66\u9a13\u3092\u65e5\u672c\u3067\u958b\u59cb\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","og_locale":"ja_JP","og_type":"article","og_title":"CoreTissue Starts Randomized ACL Trial","og_description":"CoreTissue BioEngineering has launched a randomized controlled cohort study for its ACL reconstruction treatment clinical trial in Japan.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","og_site_name":"itbusinesstoday","article_published_time":"2026-05-11T11:23:41+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"CoreTissue Launches ACL Clinical Cohort Study","datePublished":"2026-05-11T11:23:41+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/"},"wordCount":295,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","keywords":["Biotech","clinical trial","CoreTissue BioEngineering","Health Technology","Medical Devices"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/","name":"\u30b3\u30a2\u30c6\u30a3\u30c3\u30b7\u30e5\u304c\u7121\u4f5c\u70ba\u5316ACL\u8a66\u9a13\u3092\u958b\u59cb","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","datePublished":"2026-05-11T11:23:41+00:00","description":"\u30b3\u30a2\u30c6\u30a3\u30c3\u30b7\u30e5\u30fb\u30d0\u30a4\u30aa\u30a8\u30f3\u30b8\u30cb\u30a2\u30ea\u30f3\u30b0\u306f\u3001ACL\u518d\u5efa\u6cbb\u7642\u81e8\u5e8a\u8a66\u9a13\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u30b3\u30db\u30fc\u30c8\u8a66\u9a13\u3092\u65e5\u672c\u3067\u958b\u59cb\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/05\/Japanese-Medtech-Startup_-CoreTissue-BioEngineering_-Initiates-Randomized-Controlled-Cohort-in-the-Clinical-Trial-for-Anterior-Cruciate-Ligament-ACL-Reconstruction-Treatment.webp","width":1200,"height":800,"caption":"CoreTissue BioEngineering"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/coretissue-launches-acl-clinical-cohort-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"CoreTissue Launches ACL Clinical Cohort Study"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/32688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=32688"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/32688\/revisions"}],"predecessor-version":[{"id":32690,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/32688\/revisions\/32690"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/32689"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=32688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=32688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=32688"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=32688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}